Hashimoto’s thyroiditis — a therapeutic or surgical problem? (Literature review)





Hashimoto’s thyroiditis, therapeutic approach, choice of treatment method, review


More than a hundred-year history of the study of Hashimoto’s thyroiditis testifies to the urgency of the disease and the theoretical and practical problems not solved yet. From a practical point of view, it is important to choose the therapeutic approach and treatment method. The complexity of the pathogenesis of this autoimmune process, which from a local, organ-specific subsequently acquires systemic features, creates certain difficulties for diagnosis and treatment. Accordingly, the clinical picture of the disease changes from local symptoms and hypothyroidism to multifaceted extrathyroid symptoms. They include arthralgia and muscle pain, mental and memory disorders, problems with women fertility, behavioral responses and quality of life. Therefore, therapeutic approach and methods of treatment should correspond to changes in the nature of the pathological process, its activity and clinical course of the disease. Today, it looks simplistic, focused only on drug treatment. There is no pathogenic treatment, and thyroid hormone replacement therapy only relieves the symptoms of hypothyroidism and does not affect the course of the autoimmune process. Hashimoto’s thyroiditis problem is associated with a steadily growing incidence and an increase in the number of patients with extrathyroid lesions and a severe clinical course. In recent years, publications are appearing in the literature that have raised questions about the feasibility of surgical treatment, and thyroidectomy is suggested a method of choice. In this review, we have attempted to analyze publications, which are based on the literature data about the issues raised over the past two decades. Almost all papers emphasize the need to eliminate the active focus of autoimmune aggression. In this regard, the choice of therapeutic approach and indications for surgical treatment remain unresolved.


Download data is not yet available.


Pankiv VI. Thyroiditis. Mìžnarodnij endokrinologìčnij žurnal. 2012;6(46):139-146. (in Ukrainian).

Sheremet MI, Shidlovskiy VА, Sydorchuk LP. Autoimmune thyroiditis. Modern views on the pathogenesis and treatment (literature review). Endocrynologia. 2014;19(3):227-235. (in Ukrainian).

Dedov II, Troshina YeA, Antonova SS, Alexandrova GF, Zilov AV. Autoimmune thyroid disease: state of the art. Problemi Endocrinologii. 2002;48(2):6-13. doi:10.14341/probl11500. (in Russian).

Pankiv VI. Praktychna tyreoi'dologija [Practical thyroidology]. Donetsk: Publisher Zaslavsky OYu; 2011. 224 p. (in Ukrainian).

Fjaellegaard K, Kvetny J, Allerup PN, Bech P, Ellervik C. Well-being and depression in individuals with subclinical hypothyroidism and thyroid autoimmunity - a general population study. Nord J Psychiatry. 2015;69(1):73‐78. doi:10.3109/08039488.2014.929741.

Krysiak R, Drosdzol-Cop A, Skrzypulec-Plinta V, Okopien B. Sexual function and depressive symptoms in young women with thyroid autoimmunity and subclinical hypothyroidism. Clin Endocrinol (Oxf). 2016;84(6):925‐931. doi:10.1111/cen.12956.

Tronko MD, Kovalenko AYe, Tarashchenko YuM, Ostafiychuk MV. Surgical aspects of thyrotoxicosis and chronic autoimmune thyroiditis (review of literature and own data). Journal of the NAMSU. 2018;24(3-4):258-267. (in Ukrainian).

Gardner DG, Shoback D. Greenspan's Basic & Clinical Endocrinology. 9th ed. New York: McGraw-Hill Education/Medical; 2011. 896 p.

Bobyr'ova LJe, Muravl'ova OV, Gorodyns'ka OJu. Principles of differential therapy of autoimmune thyroiditis depending on the nature of metabolic disorders. Actual Problems of the Modern Medicine: Stomatological Academy. 2014;14(45):28-34. (in Ukrainian).

Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14(2):174‐180. doi:10.1016/j.autrev.2014.10.016.

Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roliński J. Immune disorders in Hashimoto's thyroiditis: what do we know so far? J Immunol Res. 2015;2015:979167. doi:10.1155/2015/979167.

Bektas Uysal H, Ayhan M. Autoimmunity affects health-related quality of life in patients with Hashimoto's thyroiditis. Kaohsiung J Med Sci. 2016;32(8):427‐433. doi:10.1016/j.kjms.2016.06.006.

Punzi L, Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine. 2004;71(4):275‐283. doi:10.1016/j.jbspin.2003.06.005.

Punzi L, Schiavon F, Ramonda R, Cavasin F, Ruffatti A, Todesco S. Anti-thyroid microsomal antibody in synovial fluid as a revealing feature of seronegative autoimmune thyroiditis. Clin Rheumatol. 1991;10(2):181‐183. doi:10.1007/BF02207661.

Weetman AP, McGregor AM, Lazarus JH, Hall R. Thyroid antibodies are produced by thyroid-derived lymphocytes. Clin Exp Immunol. 1982;48(1):196‐200.

Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab. 2008;4(7):394‐405. doi:10.1038/ncpendmet0846.

Peyneau M, Kavian N, Chouzenoux S, et al. Role of thyroid dysimmunity and thyroid hormones in endometriosis. Proc Natl Acad Sci U S A. 2019;116(24):11894‐11899. doi:10.1073/pnas.1820469116.

Artini PG, Uccelli A, Papini F, et al. Infertility and pregnancy loss in euthyroid women with thyroid autoimmunity. Gynecol Endocrinol. 2013;29(1):36‐41. doi:10.3109/09513590.2012.705391.

Karanikas G, Schuetz M, Wahl K, et al. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis. Clin Endocrinol (Oxf). 2005;63(2):191‐196. doi:10.1111/j.1365-2265.2005.02324.x.

Norheim KB, Jonsson G, Omdal R. Biological mechanisms of chronic fatigue. Rheumatology (Oxford). 2011;50(6):1009‐1018. doi:10.1093/rheumatology/keq454.

Omdal R, Larssen E, Brede C, et al. A proteomic signature of fatigue in primary Sjogren’s syndrome. Annals of the Rheumatic Diseases. 2017;76(2):184-185. doi:10.1136/annrheumdis-2017-eular.3973.

Bårdsen K, Nilsen MM, Kvaløy JT, Norheim KB, Jonsson G, Omdal R. Heat shock proteins and chronic fatigue in primary Sjögren's syndrome. Innate Immun. 2016;22(3):162‐167. doi:10.1177/1753425916633236.

Montoya JG, Holmes TH, Anderson JN, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci U S A. 2017;114(34):E7150‐E7158. doi:10.1073/pnas.1710519114.

Krysiak R, Okopien B. The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. J Clin Endocrinol Metab. 2011;96(7):2206‐2215. doi:10.1210/jc.2010-2986.

Guldvog I, Reitsma LC, Johnsen L, et al. Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial. Ann Intern Med. 2019;170(7):453‐464. doi:10.7326/M18-0284.

Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, Sánchez-Madrid F, González-Amaro R, Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab. 2010;95(2):953‐962. doi:10.1210/jc.2009-1719.

Bai X, Sun J, Wang W, et al. Increased differentiation of Th22 cells in Hashimoto's thyroiditis. Endocr J. 2014;61(12):1181‐1190. doi:10.1507/endocrj.EJ14-0265.

Hiromatsu Y, Satoh H, Amino N. Hashimoto's thyroiditis: history and future outlook. Hormones (Athens). 2013;12(1):12‐18. doi:10.1007/BF03401282.

Vibhavasu S. Thyroid surgery for patients with Hashimoto’s disease. Clinical Thyroidology for the Public. 2019;12(7):8-9.

Carli AF, Lottini M, Testa M, Neri A. Surgical treatment of Hashimoto's thyroiditis. Personal experience. Minerva Chir. 2002;57(2):117‐122. (in Italian).

Yoo WS, Chung HK. Recent Advances in Autoimmune Thyroid Diseases. Endocrinol Metab (Seoul). 2016;31(3):379‐385. doi:10.3803/EnM.2016.31.3.379.

Williams DE, Le SN, Godlewska M, Hoke DE, Buckle AM. Thyroid Peroxidase as an Autoantigen in Hashimoto's Disease: Structure, Function, and Antigenicity. Horm Metab Res. 2018;50(12):908‐921. doi:10.1055/a-0717-5514.

Pradeep PV, Ragavan M, Ramakrishna BA, Jayasree B, Skandha SH. Surgery in Hashimoto's thyroiditis: indications, complications, and associated cancers. J Postgrad Med. 2011;57(2):120‐122. doi:10.4103/0022-3859.81867.

Shimizu K, Nakajima Y, Kitagawa W, et al. Surgical therapy in Hashimoto's thyroiditis. J Nippon Med Sch. 2003;70(1):34‐39. doi:10.1272/jnms.70.34.

McManus C, Luo J, Sippel R, Chen H. Should patients with symptomatic Hashimoto's thyroiditis pursue surgery? J Surg Res. 2011;170(1):52‐55. doi:10.1016/j.jss.2011.01.037.

Nenkov R, Radev R, Khristozov K, et al. Hashimoto's Thyroiditis: Indications for Surgical Treatment. Khirurgiia (Sofiia). 2005;(3):28‐32. (in Bulgarian).

Shidlovskiy VА, Sheremet MI. Current approaches to the surgical treatment of autoimmune thyroiditis. Endocrynologia. 2014;19(4):365. (in Ukrainian).

Kon YC, DeGroot LJ. Painful Hashimoto's thyroiditis as an indication for thyroidectomy: clinical characteristics and outcome in seven patients. J Clin Endocrinol Metab. 2003;88(6):2667‐2672. doi:10.1210/jc.2002-021498.

Ruggeri RM, Trimarchi F, Giuffrida G, et al. Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence. Eur J Endocrinol. 2017;176(2):133‐141. doi:10.1530/EJE-16-0737.

Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391‐397. doi:10.1016/j.autrev.2014.01.007.

Dedov II, Melnichenko GA. Endokrinologiia. Natsional'noe rukovodstvo. Kratkoe izdanie [Endocrinology. National leadership. Brief Edition]. 2nd ed. Мoscow: GEOTAR-Media; 2018. 832 p. (in Russian).

Kramer CK, von Mühlen D, Kritz-Silverstein D, Barrett-Connor E. Treated hypothyroidism, cognitive function, and depressed mood in old age: the Rancho Bernardo Study. Eur J Endocrinol. 2009;161(6):917‐921. doi:10.1530/EJE-09-0606.

Dayan CM, Panicker V. Hypothyroidism and depression. Eur Thyroid J. 2013;2(3):168‐179. doi:10.1159/000353777.

Leyhe T, Müssig K. Cognitive and affective dysfunctions in autoimmune thyroiditis. Brain Behav Immun. 2014;41:261‐266. doi:10.1016/j.bbi.2014.03.008.

Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473‐483.

Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998;45(1):53‐65. doi:10.1016/s0022-3999(97)00291-2.

Loge JH, Kaasa S. Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med. 1998;26(4):250‐258.

Fridkis-Hareli M. Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases. J Autoimmune Dis. 2008;5:1. doi:10.1186/1740-2557-5-1.

Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012;345:e7895. doi:10.1136/bmj.e7895.



How to Cite

Shidlovskyi, V., Shidlovskyi А., Sheremet, M., & Tverdohlib, V. (2021). Hashimoto’s thyroiditis — a therapeutic or surgical problem? (Literature review). INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), 16(3), 245–250. https://doi.org/10.22141/2224-0721.16.3.2020.205274



Literature Review